Only one study by Hu et al. compared both GFAP and UCH-L1 serum levels in AIS patients with healthy controls and determined increased levels at the early stage of stroke with a certain correlation to the severity of cerebral infarction, which is consistent with our results [36]. This evidence concerns the gene GFAP and cerebral infarction.